CVC Credit continues support for Curium through its Capital Solutions strategy

CVC Credit is pleased to announce that it has extended its relationship with Curium, a leading provider of nuclear medicine, through the provision of debt facilities and equity to support the recent refinancing of the business. The transaction saw CVC Credit’s existing investments repaid and CVC Credit reinvest to continue to support Curium’s impressive ongoing growth story.

Headquartered in Paris, Curium specialises in the manufacturing and distribution of radiopharmaceutical products used globally in early detection of cancer, as well as heart, brain, lungs and bone diseases. The business is a global market leader and serves more than 6,000 long term customers in over 70 countries on six continents, delivering diagnostics to more than 14 million patients annually.

Having supported Curium since 2020, CVC Credit was able to use its longstanding relationship with the sponsor and business to lead this latest transaction. CVC Credit’s deep knowledge of the business was supplemented with additional knowledge provided by CVC Private Equity’s specialist Healthcare team, who know the space well. This additional insight enhanced CVC Credit’s ability to move swiftly and with conviction.

CVC Credit’s Capital Solutions strategy is uniquely positioned to provide bespoke capital solutions for large-cap, sponsor-backed European businesses. It focuses on primary junior capital or structured equity to support M&A, refinancings and/or liquidity events.

Miguel Toney, Partner in CVC Credit’s Private Credit team, said: “We are delighted to further extend our relationship with Curium and with Cap Vest which, in the six years since we first invested, continues to build out its leadership position in the growing nuclear medicine sector. Through its long-term customer relationships and experienced management team, Curium remains very well-placed to continue along its impressive growth trajectory.”

Andrew Davies, Head of CVC Credit, added: “We find ourselves in an increasingly complex investment environment where our Capital Solutions strategy, with the support of CVC’s integrated network, is very well-positioned to originate attractive investment opportunities in high quality businesses, which require bespoke financing solutions to fund their ongoing strategic initiatives.”

CVC Credit Capital Solutions is very well placed to support sponsors’ and business requirements in an increasing complex market. Other businesses recently supported by CVC Credit Capital Solutions include: American Heart of Poland, Novus Foods and SYNLAB AG.